Kliniska studier för Lupus i Missouri
8 studier för Lupus söker deltagare vid platser i Missouri.
Städer i Missouri
Officiell studietext (engelska)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50682, Kansas City
RekryterarFas 3
Ålder 16 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT06617325A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
- Research Site, Kansas City
RekryterarFas 3
Ålder 18 till 70 · Alla kön · Uppdaterad 25 sep. 2026 · NCT07430306Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
- Siteman Cancer Center at West County Hospital, Creve Coeur
- University Health Truman Medical Center, Kansas City
- och 6 fler
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 23 sep. 2026 · NCT03816345Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
- Research Site, St Louis
RekryterarFas 1
Ålder 18 till 65 · Alla kön · Uppdaterad 18 sep. 2026 · NCT07201558A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
- Research Site, St Louis
RekryterarFas 1/2
Ålder 18 till 70 · Alla kön · Uppdaterad 10 sep. 2026 · NCT06897930A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
- Washington University School of Medicine, St Louis
RekryterarFas 1
Ålder 18 till 70 · Alla kön · Uppdaterad 28 aug. 2026 · NCT06925542A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
- Investigative Site, Saint Joseph
RekryterarFas 2
Ålder 18 till 80 · Alla kön · Uppdaterad 27 juli 2026 · NCT07260877Lupus Landmark Study: A Prospective Registry and Biorepository
- Washington University, St Louis
RekryterarObservationsstudie
Ålder 18 till 110 · Alla kön · Uppdaterad 15 apr. 2026 · NCT05934149Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.